ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
201344-100MG |
|
2195357-71-0 |
3-[[(4S)-4,5-Dihydro-2-methyl-4-oxazolyl]methyl]-1H-indole ≥95%,99%e.e. |
100MG | C13H14N2O | |
201343-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-3,3-dimethyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C37H37ClIrN3O3 | |
201342-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-2-(1,3-dioxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)-3,3-dimethyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C37H37ClIrN3O3 | |
201341-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-3,3-dimethyl-N-(quinolin-8-yl)-2-(4,5,6,7-tetrabromo-1,3-dioxoisoindolin-2-yl)butanamide]-Iridium ≥95%,- |
100MG | C33H31Br4ClIrN3O3 | |
201340-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-3-(3,5-dimethoxybenzyl)-4-(3,5-dimethoxyphenyl)-2-(1,3-dioxoisoindolin-2-yl)-3-methyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C49H51ClIrN3O7 | |
201339-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][dimethyl-4,4'-(2-(1-(1,3-dioxoisoindolin-2-yl)-2-oxo-2-(quinolin-8-ylamino)ethyl)-2-methylpropane-1,3-diyl)(S)-dibenzoate]-Iridium ≥95%,- |
100MG | C49H47ClIrN3O7 | |
201338-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-N-(5-chloroquinolin-8-yl)-2-(1,3-dioxoisoindolin-2-yl)-3,3-dimethylbutanamide]-Iridium ≥95%,- |
100MG | C33H34Cl2IrN3O3 | |
201337-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-2-(1,3-dioxoisoindolin-2-yl)-N-(5-methoxyquinolin-8-yl)-3,3-dimethylbutanamide]-Iridium ≥95%,- |
100MG | C34H37ClIrN3O4 | |
201336-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-2-(1,3-dioxoisoindolin-2-yl)-3,3-bis(4-methoxybenzyl)-4-(4-methoxyphenyl)-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C54H53ClIrN3O6 | |
201335-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][(S)-2-(1,3-dioxoisoindolin-2-yl)-3-(4-methoxybenzyl)-4-(4-methoxyphenyl)-3-methyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C47H47ClIrN3O5 | |
201334-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][2-(1,3-dioxoisoindolin-2-yl)-4-(4-methoxyphenyl)-3,3-dimethyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C40H41ClIrN3O4 | |
201333-100MG |
|
NA |
Chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl][2-(1,3-dioxoisoindolin-2-yl)-3,3-dimethyl-N-(quinolin-8-yl)butanamide]-Iridium ≥95%,- |
100MG | C33H35ClIrN3O3 | |
201332-100MG |
|
2307258-14-4 |
Chloro[methyl-N-(8-quinolinyl-κN)carbamato-κN][(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-Iridium ≥95%,- |
100MG | C21H24ClIrN2O2 | |
201331-100MG |
|
NA |
(S)-4,12-Bis(bis(3,5-di-tert-butyl-4-methoxyphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C76H106O4P2 | |
201330-100MG |
|
NA |
(R)-4,12-Bis(bis(3,5-di-tert-butyl-4-methoxyphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C76H106O4P2 | |
201329-100MG |
|
NA |
(S)-4,12-Bis(bis(4-methoxyphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C44H42O4P2 | |
201328-100MG |
|
364732-86-5 |
(R)-4,12-Bis(bis(4-methoxyphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C44H42O4P2 | |
201327-100MG |
|
325168-88-5 |
(S)-4,12-Bis(1,1-bis(3,5-dimethylphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C48H50P2 | |
201326-100MG |
|
325168-89-6 |
(R)-4,12-Bis(1,1-bis(3,5-dimethylphenyl)phosphine)-[2.2]paracyclophane ≥98%,99%e.e. |
100MG | C48H50P2 | |
201325-100MG |
|
443347-10-2 |
(3S)-4,4'-Bis[bis(3,5-dimethylphenyl)phosphino]-2,2',6,6'- tetramethoxy-3,3'-bipyridine ≥98%,99%e.e. |
100MG | C46H50N2O4P2 | |